C

Catalyst Pharmaceuticals
D

CPRX

23.195
USD
0.18
(0.78%)
مغلق
حجم التداول
27,812
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
2,850,952,816
أصول ذات صلة الأخبار المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).